David M. Urso
2021
In 2021, David M. Urso earned a total compensation of $2.1M as Chief Operating Officer and General Counsel at MEI Pharma, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,267 |
|---|---|
| Option Awards | $1,265,250 |
| Salary | $492,200 |
| Stock Awards | $174,500 |
| Total | $2,120,217 |
Urso received $1.3M in option awards, accounting for 60% of the total pay in 2021.
Urso also received $188.3K in non-equity incentive plan, $492.2K in salary and $174.5K in stock awards.
Rankings
In 2021, David M. Urso's compensation ranked 5,833rd out of 12,405 executives tracked by ExecPay. In other words, Urso earned more than 53.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,833 out of 12,405 | 53rd |
Division Manufacturing | 2,469 out of 5,494 | 55th |
Major group Chemicals And Allied Products | 1,070 out of 2,369 | 55th |
Industry group Drugs | 952 out of 2,090 | 54th |
Industry Pharmaceutical Preparations | 682 out of 1,537 | 56th |
Source: SEC filing on October 28, 2021.
Urso's colleagues
We found four more compensation records of executives who worked with David M. Urso at MEI Pharma in 2021.